April 7, 2026
Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *